Co-Crystalline Solid Solution Affords a High-Soluble and Fast-Absorbing Form of Praziquantel
Open Access
- 8 March 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (4) , 2009-2016
Abstract
No abstract availableKeywords
Funding Information
- Science Foundation Ireland (15/sirg/3577)
This publication has 33 references indexed in Scilit:
- EXPO2013: a kit of tools for phasing crystal structures from powder dataJournal of Applied Crystallography, 2013
- Drug Salt Formation via Mechanochemistry: The Case Study of VincamineMolecular Pharmaceutics, 2012
- Cocrystals of Active Pharmaceutical Ingredients—Praziquantel in Combination with Oxalic, Malonic, Succinic, Maleic, Fumaric, Glutaric, Adipic, And Pimelic AcidsCrystal Growth & Design, 2012
- Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parametersJournal of Molecular Modeling, 2012
- Solubility Advantage of Amorphous Drugs and Pharmaceutical CocrystalsCrystal Growth & Design, 2011
- PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft ExcelComputer Methods and Programs in Biomedicine, 2010
- Taste, A New Incentive to Switch to (R)-Praziquantel in Schistosomiasis TreatmentPLOS Neglected Tropical Diseases, 2009
- What is a co-crystal?CrystEngComm, 2007
- Crystal Engineering Approach To Forming Cocrystals of Amine Hydrochlorides with Organic Acids. Molecular Complexes of Fluoxetine Hydrochloride with Benzoic, Succinic, and Fumaric AcidsJournal of the American Chemical Society, 2004
- A simple method for oral administration of drugs in solid form to fully conscious ratsLaboratory Animals, 1983